Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Life Sciences has informed that the Board of Directors of the company at its meeting held today June 5, 2020, has taken on record and approved the Audited Standalone and Consolidated Financial Results of the Company under Ind AS for the quarter and for the year ended 31st March, 2020 and approved the various matters as enclosed. The board meeting commenced at 11.30 am and concluded at 13.45 pm.
The above information is a part of company’s filings submitted to BSE.
